FDA Speaks Loudly On Approved Claims Language In Post Foods Warning
This article was originally published in The Tan Sheet
Similar claims likely are made for products marketed by others firms of various sizes, but a single warning letter to a manufacturer the size of Post Food speaks louder than similar letters to numerous smaller companies.
You may also be interested in...
Kellogg Co. disagrees with ConAgra’s petition to FDA for a qualified health claim linking whole grain consumption with reduced risk of type 2 diabetes. Other experts question ConAgra’s supporting evidence and maintain fiber content should be emphasized over whole grains in product labeling.
“We ought to deal with this. There are questions on long-term safety and questions on efficacy claims that are just not proven,” says the Maryland Republican. “The biggest threat hanging over, in my mind, the farmers who want to grow hemp, is what if the FDA comes out tomorrow and says, ‘You can't sell any product’? The market collapses,”he said at a CBD policy conference.